148 related articles for article (PubMed ID: 23567627)
1. Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology.
Liu N; Liang W; Ma X; Li X; Ning B; Cheng C; Ou G; Wang B; Zhang J; Gao Z
Biosens Bioelectron; 2013 Sep; 47():92-8. PubMed ID: 23567627
[TBL] [Abstract][Full Text] [Related]
2. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic-integrated patterned ITO immunosensor for rapid detection of prostate-specific membrane antigen biomarker in prostate cancer.
Seenivasan R; Singh CK; Warrick JW; Ahmad N; Gunasekaran S
Biosens Bioelectron; 2017 Sep; 95():160-167. PubMed ID: 28445813
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen.
Murphy GP; Barren RJ; Erickson SJ; Bowes VA; Wolfert RL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Kenny GM; Ragde H; Boynton AL; Holmes EH
Cancer; 1996 Aug; 78(4):809-18. PubMed ID: 8756376
[TBL] [Abstract][Full Text] [Related]
5. Fe
Sharafeldin M; Bishop GW; Bhakta S; El-Sawy A; Suib SL; Rusling JF
Biosens Bioelectron; 2017 May; 91():359-366. PubMed ID: 28056439
[TBL] [Abstract][Full Text] [Related]
6. [Related biomarkers in the diagnosis of prostate cancer].
Xu YM; Liu HZ
Zhonghua Nan Ke Xue; 2015 Oct; 21(10):937-40. PubMed ID: 26665686
[TBL] [Abstract][Full Text] [Related]
7. Real-time quantitative RT-PCR assay of prostate-specific antigen and prostate-specific membrane antigen in peripheral blood for detection of prostate cancer micrometastasis.
Zhang L; Wang CY; Yang R; Shi J; Fu R; Chen L; Klocker H; Zhang J
Urol Oncol; 2008; 26(6):634-40. PubMed ID: 18367130
[TBL] [Abstract][Full Text] [Related]
8. Label-free determination of prostate specific membrane antigen in human whole blood at nanomolar levels by magnetically assisted surface enhanced Raman spectroscopy.
Chaloupková Z; Balzerová A; Bařinková J; Medříková Z; Šácha P; Beneš P; Ranc V; Konvalinka J; Zbořil R
Anal Chim Acta; 2018 Jan; 997():44-51. PubMed ID: 29149993
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of expression of PSA, hK2, PSMA in the peripheral blood of patients with prostate cancer].
Cui WG; Zhao H; Song YZ; Zhang J; Zhang LG; Shi JD; Qiang WM
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):479-81. PubMed ID: 15555338
[TBL] [Abstract][Full Text] [Related]
11. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific membrane antigen: current and future utility.
Gregorakis AK; Holmes EH; Murphy GP
Semin Urol Oncol; 1998 Feb; 16(1):2-12. PubMed ID: 9508077
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.
Li J; Dai L; Lei N; Xing M; Li P; Luo C; Casiano CA; Zhang JY
Oncotarget; 2016 Jul; 7(28):43546-43556. PubMed ID: 27286458
[TBL] [Abstract][Full Text] [Related]
14. [Alternative tests to PSA for prostate cancer diagnosis].
Defilippi E; Zitella A; Tizzani A
Urologia; 2011; 78(2):75-81. PubMed ID: 21553390
[TBL] [Abstract][Full Text] [Related]
15. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
[TBL] [Abstract][Full Text] [Related]
16. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
[TBL] [Abstract][Full Text] [Related]
17. Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy.
Yates DR; Rouprêt M; Drouin SJ; Comperat E; Ricci S; Lacave R; Sèbe P; Cancel-Tassin G; Bitker MO; Cussenot O
Prostate; 2012 Sep; 72(12):1382-8. PubMed ID: 22228175
[TBL] [Abstract][Full Text] [Related]
18. Precise prostate cancer diagnosis using fluorescent nanoprobes for detecting PSA and PSMA in serum.
Ouyang M; Jia M; Chang Z; Wang Y; Wang K; Gao X; Tang B
Chem Commun (Camb); 2024 May; 60(39):5181-5184. PubMed ID: 38647078
[TBL] [Abstract][Full Text] [Related]
19. [Significance of current bio- and molecular-markers in urological cancers].
Shimazui T; Akaza H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1008-14. PubMed ID: 15272577
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system.
Arndt C; Feldmann A; Koristka S; Cartellieri M; Dimmel M; Ehninger A; Ehninger G; Bachmann M
Prostate; 2014 Sep; 74(13):1335-46. PubMed ID: 25053443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
